Exosomes are vesicles created by the cell to transport components through the body. The particular type of exosome that is creating excitement in Alzheimer’s research is exosomes that deliver anti-inflammatory agents to the brain. Celltex Therapeutics Corp. and Texas A&M University Health Science Center College of Medicine Institute for Regenerative Medicine have teamed up to pursue research on how to utilize exosomes to reduce inflammation in the brain. Texas A&M’s previous research on mesenchymal stem cells (MSC) found that the exosomes produced by MSC can be utilized to reduce inflammation. Collaborating with Celltex’s stem cell process will allow research to be conducted on whether a large amount of MSC exosomes can be utilized as a therapy for Alzheimer’s disease. These exosomes are thought to decrease cognitive decline by decreasing brain inflammation and promoting neuronal repair mechanisms. The research will begin with animals models but hopes to quickly move to human clinical trails and the development of a new treatment for Alzheimer’s disease.
Author: Olivia Pulsinelli
Date Retrieved: February 9th 2018